Kiser, Kathryn
Oral Anticoagulation Therapy
Part I. Introduction
1. Introduction
Kathryn Kiser
Part II. Atrial Fibrillation
2. CHA
Lea E. Pena
3. Male with Priority of Ischemic Stroke Reduction
David Parra, Augustus Hough
4. Choosing an Anticoagulant in an Elderly Patient
Jena I. Burkhart
5. Patient with Prior History of GI Hemorrhage
Michael Brenner, David Parra
6. Patients with a History of Intracranial Hemorrhage
Jordan D. Long, Douglas C. Anderson
7. Concerns with Anticoagulant Adherence
David Parra, Michael Brenner
8. Oral Anticoagulants in Stable Moderate Chronic Kidney Disease
James C. Lee
9. Oral Anticoagulants in Severe Renal Dysfunction
Jennifer Babin
10. Oral Anticoagulants in Patients with Variable Renal Function
James C. Lee
11. Patient with Concomitant Stable Coronary Artery Disease
Michael Brenner, Augustus Hough
12. Patient with Concomitant Acute Venous Thromboembolism
Lea E. Pena
13. Patient with Concomitant Mitral Valve Stenosis
Augustus Hough, Michael Brenner
14. Patient with Concomitant Aortic Valve Stenosis
Augustus Hough, David Parra
Part III. Warfarin Management
15. Best Practice for Switching Stable Warfarin Patients
Dave L. Dixon
16. Patient-Centered Strategies for Improving Warfarin Management
James C. Lee
Part IV. Venous Thromboembolism (VTE)
17. Provoked Versus Unprovoked Venous Thromboembolism
Jasmine M. Pittman
18. Venous Thromboembolism (VTE) Prophylaxis in Hip and Knee Replacement Surgery
Mary G. Amato, Danielle Carter
19. Venous Thromboembolism (VTE) Prophylaxis in the Intensive Care Unit (ICU)
Dillon Elliott
20. VTE and Recent Drug Eluting Stent (DES) Placement
Wendy M. Gabriel
21. Acute VTE in a Patient with Moderate Chronic Kidney Disease
Brenda Pahl, Douglas Anderson
22. Oral Anticoagulation and Duration in Recurrent Venous Thromboembolism (VTE)
Regina Arellano
23. Pulmonary Embolism (PE) with Thrombolytic Therapy
Justin M. Schmidt
Part V. Acute Coronary Syndrome (ACS)
24. Patient on Oral Anticoagulant Presenting with ACS
Craig J. Beavers
25. Oral Anticoagulant Therapy Post-Percutaneous Coronary Intervention
Craig J. Beavers
26. ST-Segment Elevation Myocardial Infarction (Lytic Candidate) on Oral Anticoagulant
Craig J. Beavers
27. ACS with Bypass Surgery
Craig J. Beavers
Part VI. Drug Interactions
28. Anticoagulant Drug-Drug Interactions with CYP 3A4 Inhibitors
Lea E. Pena
29. Significance of P-glycoprotein (P-gp) Drug-Drug Interactions
Dave L. Dixon
30. Considerations with Pharmacodynamic Drug-Drug Interactions
Jill S. Borchert
31. Management of Direct Oral Anticoagulants with Mixed P-gp/3A4 Drug-Drug Interactions
Kathryn Wdowiarz
32. Pharmacokinetic Drug-Drug Interactions with Warfarin
Rachel C. Ieuter
Part VII. Special Populations
33. Chronic Pain Management with Anticoagulation
Leah Sera
34. Anticoagulation Management in Atrial Fibrillation Catheter Ablation
Brian Cryder
35. Anticoagulation Management Considerations for Mechanical Valves
Denise M. Kolanczyk
36. Management of Antiphospholipid Antibody Syndrome
Margaret A. Felczak
37. Venous Thromboembolism and Pregnancy
Erika L. Hellenbart
38. Venous Thromboembolism in Active Malignancy
Margaret A. Felczak
39. Anticoagulation Management in Patients Undergoing Gastric Bypass Procedures
Brian Cryder
40. Patient Presenting with Minor Bleeding
Daniel M. Witt
41. Patient Presenting with Major, Life-Threatening Bleeding
Daniel M. Witt
42. Overdose of Dabigatran
Alicia Potter DeFalco
Keywords: Medicine & Public Health, Cardiology
- Editor
- Kiser, Kathryn
- Publisher
- Springer
- Publication year
- 2017
- Language
- en
- Edition
- 1
- Page amount
- 10 pages
- Category
- Medicine, Health Care, Mode
- Format
- Ebook
- eISBN (PDF)
- 9783319546438
- Printed ISBN
- 978-3-319-54641-4